Etomidate (USAN, INN, BAN) (marketed as Amidate) is a short-acting intravenous anaesthetic agent used for the induction of general anaesthesia and sedation for short procedures such as reduction of dislocated joints, tracheal intubation, and cardioversion. It was discovered at Janssen Pharmaceutica in 1964 and was introduced as an intravenous agent in 1972 in Europe and in 1983 in the United States.

CAS：33125-97-2
中文别名：R-(+)-1-(1-苯乙基)-1-氢-咪唑-5-甲酸乙酯;(R)-(+)-1-(1-苯乙基)-1-氢-咪唑-5-甲酸乙酯;(R)-1-(1-苯基乙基)-1H-咪唑-5-甲酸乙酯;乙苄咪唑;
英文别名：(R)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate;(R)-(+)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylic Acid Ethyl Ester;PROPISCIN;R-1665;AMIDATE;RADENARCON;Etomidate;Amidate,R16659;D-ETOMIDATE;HYPNOMIDATE;Amidate R16659;Ethyl (R)-(+)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylate;
分子式：C14H16N2O2
分子量：244.289
精确质量：244.121
Psa：44.12
Logp：2.6691

MDL号：MFCD00869295

外观与性状：白色粉末
密度：1.11g/cm3
沸点：391.5ºC at 760mmHg
熔点：72-74ºC
闪点：190.6ºC
折射率：1.561
稳定性：Stable at normal temperatures and pressures.
储存条件：2-8ºC

安全说明：S36
危险类别码：R22
海关编码：2933990090
危险品标志：Xn
危险标志：GHS07, GHS09
危险性防范说明：P273
信号词：Warning
危险性描述：H302; H400